Letters to the Editor

ONF 2007, 33(3), 513-514. DOI: 10.1188/06.ONF.513-514

Jump to a section

    References

    Abernethy, A.P., Currow, D.C., Frith, P., Fazekas, B.S., McHugh, A., & Bui, C. (2003). Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ, 327, 523-528.
    Abernethy, A.P., Currow, D.C., Frith, P.A., & Fazekas, B.A. (2005). Prescribing palliative oxygen: A clinician survey of expected benefit and patterns of use. Palliative Medicine, 19, 165-172.
    Booth, S., Anderson, H., Swannick, M., Wade, R., Kite, S., & Johnson, M. (2004). The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respiratory Medicine, 98(1), 66-77.
    Jantarakupt, P., & Porock, D. (2005). Dyspnea management in lung cancer: Applying the evidence from chronic obstructive pulmonary disease. Oncology Nursing Forum, 32, 785-797.
    Jennings, A.L., Davies, A.N., Higgins, J.P., Gibbs, J.S., & Broadley, K.E. (2002). A systematic review of the use of opioids in the management of dyspnoea. Thorax, 57, 939-944.